218 related articles for article (PubMed ID: 12700401)
1. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.
McQueen CA; Chau B
Toxicol Sci; 2003 Jun; 73(2):279-86. PubMed ID: 12700401
[TBL] [Abstract][Full Text] [Related]
2. The effects of genetic variation in N-acetyltransferases on 4-aminobiphenyl genotoxicity in mouse liver.
McQueen CA; Chau B; Erickson RP; Tjalkens RB; Philbert MA
Chem Biol Interact; 2003 Jul; 146(1):51-60. PubMed ID: 12902152
[TBL] [Abstract][Full Text] [Related]
3. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice.
Sugamori KS; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Mol Pharmacol; 2003 Jul; 64(1):170-9. PubMed ID: 12815173
[TBL] [Abstract][Full Text] [Related]
4. Developmental expression of N-acetyltransferases in C57BI/6 mice.
Mitchell MK; Futscher BW; McQueen CA
Drug Metab Dispos; 1999 Feb; 27(2):261-4. PubMed ID: 9929513
[TBL] [Abstract][Full Text] [Related]
5. Effect of arylamine acetyltransferase Nat3 gene knockout on N-acetylation in the mouse.
Sugamori KS; Brenneman D; Wong S; Gaedigk A; Yu V; Abramovici H; Rozmahel R; Grant DM
Drug Metab Dispos; 2007 Jul; 35(7):1064-70. PubMed ID: 17403913
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
7. Prenatal expression of N-acetyltransferases in C57Bl/6 mice.
McQueen CA; Mitchell MK; Dang LN; Chau B; Tjalkens RB; Philbert MA
Chem Biol Interact; 2003 Mar; 145(1):77-87. PubMed ID: 12606156
[TBL] [Abstract][Full Text] [Related]
8. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
9. Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol.
Kirlin WG; Trinidad A; Yerokun T; Ogolla F; Ferguson RJ; Andrews AF; Brady PK; Hein DW
Cancer Res; 1989 May; 49(9):2448-54. PubMed ID: 2784998
[TBL] [Abstract][Full Text] [Related]
10. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice.
Loehle JA; Cornish V; Wakefield L; Doll MA; Neale JR; Zang Y; Sim E; Hein DW
J Pharmacol Exp Ther; 2006 Nov; 319(2):724-8. PubMed ID: 16857729
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice.
Sugamori KS; Brenneman D; Grant DM
Drug Metab Dispos; 2006 Oct; 34(10):1697-702. PubMed ID: 16815960
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse.
Leff MA; Epstein PN; Doll MA; Fretland AJ; Devanaboyina US; Rustan TD; Hein DW
J Pharmacol Exp Ther; 1999 Jul; 290(1):182-7. PubMed ID: 10381774
[TBL] [Abstract][Full Text] [Related]
14. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells.
Estrada-Rodgers L; Levy GN; Weber WW
Drug Metab Dispos; 1998 May; 26(5):502-5. PubMed ID: 9571233
[TBL] [Abstract][Full Text] [Related]
15. Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.
Liu L; Von Vett A; Zhang N; Walters KJ; Wagner CR; Hanna PE
Chem Res Toxicol; 2007 Sep; 20(9):1300-8. PubMed ID: 17672512
[TBL] [Abstract][Full Text] [Related]
16. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
17. Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes.
Wang H; Wagner CR; Hanna PE
Chem Res Toxicol; 2005 Feb; 18(2):183-97. PubMed ID: 15720122
[TBL] [Abstract][Full Text] [Related]
18. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
19. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.
Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2005 Aug; 579(21):4719-23. PubMed ID: 16098511
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
